Poxel Announces Phase 1 Initiation of EYP001 for the Treatment of Chronic Hepatitis B Virus Infection by Licensing Partner ENYO Pharma SA Dec 19, 2016
Ability to Delay Type 2 Diabetes Disease Progression by Preserving Beta Cell Mass Observed in New Imeglimin Data Dec 5, 2016
Poxel to Present New Imeglimin Data Demonstrating Beta Cell Function Preservation at the 14th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease Nov 21, 2016
Poxel Presents New Data on Imeglimin and PXL770 at the European Association for the Study of Diabetes Annual Meeting Sep 15, 2016
Poxel to Present at the 18th Annual Rodman & Renshaw Global Investment Conference September 11-13th, 2016 Sep 6, 2016
Poxel to Present New Imeglimin and PXL770 Data at the 52nd European Association for the Study of Diabetes Annual Meeting Sep 6, 2016
